SCHEMBL168949

SCHEMBL168949

[CH2]CCCCC=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183299 0.97 TRPA1 (0.31)
SCHEMBL166888 0.97
SCHEMBL8734069 0.97 TRPA1 (0.31)
SCHEMBL8579729 0.97 TRPA1 (0.31)
SCHEMBL168854 0.97 TRPA1 (0.31)
SCHEMBL165910 0.97 TRPA1 (0.31)
SCHEMBL320565 0.97 TRPA1 (0.31)
SCHEMBL183105 0.97
SCHEMBL165972 0.90
SCHEMBL820047 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191482-B1 1,2,3-THIADIAZOL-5YL-UREA DERIVATIVES, USE THEREOF FOR REGULATING PLANT SENESCENCE AND PREPARATIONS CONTAINING THESE DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-03-27 EP claimed
US-20070225291-A1 Substituted Pyrazinone Compounds for the Treatment of Inflammation PFIZER INC. 2007-09-27 US claimed
EP-1678164-B1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORP (US) 2007-04-11 EP claimed
EP-1678146-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2006-07-12 EP claimed
EP-1678164-A1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2006-07-12 EP claimed
EP-1611166-A2 BUILDING SEALANT COMPOSITION Bridgestone Corporation (JP) 2006-01-04 EP claimed
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US claimed
WO-2005040133-A1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-05-06 WO claimed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO claimed
WO-2005035527-A1 SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-21 WO claimed
WO-2004090060-A2 BUILDING SEALANT COMPOSITION BRIDGESTONE CORPORATION (JP) 2004-10-21 WO claimed
EP-4400561-A1 LIQUID-CRYSTAL MEDIUM Merck Patent GmbH (DE) 2024-07-17 EP disclosed
CN-118325625-A Liquid-crystalline medium 默克专利股份有限公司 2024-07-12 CN disclosed
US-20240216312-A1 PPAR-AGONISTS FOR USE IN THE TREATMENT OF LIVER FAILURE GENFIT (FR) 2024-07-04 US disclosed
US-20240222110-A1 PARTIAL BREAKDOWN OF PRECURSORS FOR ENHANCED ALD FILM GROWTH ASM IP HOLDING B.V. (NL) 2024-07-04 US disclosed
EP-0554023-A1 Corrosion inhibitors CIBA-GEIGY AG (CH) 1993-08-04 EP disclosed
US-5183842-A Mixture of ketoacid and amine with film-forming binder, curing CIBA-GEIGY CORPORATION (US) 1993-02-02 US disclosed
EP-0496555-A2 Corrosion-inhibiting coating compositions CIBA-GEIGY AG (CH) 1992-07-29 EP disclosed
US-5128396-A Corrosion inhibiting primers on metallic substrates CIBA-GEIGY CORPORATION (US) 1992-07-07 US disclosed
EP-0412933-A1 Coating compositions CIBA-GEIGY AG (CH) 1991-02-13 EP disclosed